180 related articles for article (PubMed ID: 36685568)
1. Standard immunosuppressive treatment reduces regulatory B cells in children with autoimmune liver disease.
Yuksel M; Nazmi F; Wardat D; Akgül S; Polat E; Akyildiz M; Arikan Ç
Front Immunol; 2022; 13():1053216. PubMed ID: 36685568
[TBL] [Abstract][Full Text] [Related]
2. CD4+CD25+CD127-Foxp3+ and CD8+CD28- Tregs in Renal Transplant Recipients: Phenotypic Patterns, Association With Immunosuppressive Drugs, and Interaction With Effector CD8+ T Cells and CD19+IL-10+ Bregs.
Aly MG; Ibrahim EH; Karakizlis H; Weimer R; Opelz G; Morath C; Zeier M; Ekpoom N; Daniel V
Front Immunol; 2021; 12():716559. PubMed ID: 34335631
[TBL] [Abstract][Full Text] [Related]
3. Immunosuppressive drugs affect interferon (IFN)-γ and programmed cell death 1 (PD-1) kinetics in patients with newly diagnosed autoimmune hepatitis.
Grant CR; Holder BS; Liberal R; Heneghan MA; Ma Y; Mieli-Vergani G; Vergani D; Longhi MS
Clin Exp Immunol; 2017 Jul; 189(1):71-82. PubMed ID: 28257599
[TBL] [Abstract][Full Text] [Related]
4. The advantage of Sirolimus in amplifying regulatory B cells and regulatory T cells in liver transplant patients.
Song J; Du G; Chen W; Bao P; Li B; Lu Q; Shi B
Eur J Pharmacol; 2020 Feb; 869():172872. PubMed ID: 31846626
[TBL] [Abstract][Full Text] [Related]
5. Intrahepatic regulatory T cells in autoimmune hepatitis are associated with treatment response and depleted with current therapies.
Taubert R; Hardtke-Wolenski M; Noyan F; Wilms A; Baumann AK; Schlue J; Olek S; Falk CS; Manns MP; Jaeckel E
J Hepatol; 2014 Nov; 61(5):1106-14. PubMed ID: 24882050
[TBL] [Abstract][Full Text] [Related]
6. The role of regulatory B cells (Bregs) in the Tregs-amplifying effect of Sirolimus.
Song J; Xiao L; Du G; Gao Y; Chen W; Yang S; Fan W; Shi B
Int Immunopharmacol; 2016 Sep; 38():90-6. PubMed ID: 27258186
[TBL] [Abstract][Full Text] [Related]
7. CD4
Qu LM; Wang SH; Yang K; Brigstock DR; Sun L; Gao RP
Hepatobiliary Pancreat Dis Int; 2018 Apr; 17(2):133-139. PubMed ID: 29551296
[TBL] [Abstract][Full Text] [Related]
8. IL-10-producing regulatory B-cells suppressed effector T-cells but enhanced regulatory T-cells in chronic HBV infection.
Liu Y; Cheng LS; Wu SD; Wang SQ; Li L; She WM; Li J; Wang JY; Jiang W
Clin Sci (Lond); 2016 Jun; 130(11):907-19. PubMed ID: 26980345
[TBL] [Abstract][Full Text] [Related]
9. Foxp3⁺ Treg Cells Are Associated with Pathological Process of Autoimmune Hepatitis by Activating Methylation Modification in Autoimmune Hepatitis Patients.
Chen J; Liu W; Zhu W
Med Sci Monit; 2019 Aug; 25():6204-6212. PubMed ID: 31422415
[TBL] [Abstract][Full Text] [Related]
10. Long-term follow-up of patients with difficult to treat type 1 autoimmune hepatitis on Tacrolimus therapy.
Than NN; Wiegard C; Weiler-Normann C; Füssel K; Mann J; Hodson J; Hirschfield GM; Lohse AW; Adams DH; Schramm C; Oo YH
Scand J Gastroenterol; 2016 Mar; 51(3):329-36. PubMed ID: 26458216
[TBL] [Abstract][Full Text] [Related]
11. Deficit of circulating CD19
Zaimoku Y; Patel BA; Kajigaya S; Feng X; Alemu L; Quinones Raffo D; Groarke EM; Young NS
Br J Haematol; 2020 Aug; 190(4):610-617. PubMed ID: 32311088
[TBL] [Abstract][Full Text] [Related]
12. Assessment of intrahepatic regulatory T cells in children with autoimmune hepatitis.
Behairy BE; El-Araby HA; Abd El Kader HH; Ehsan NA; Salem ME; Zakaria HM; Khedr MA
Ann Hepatol; 2016; 15(5):682-90. PubMed ID: 27493106
[TBL] [Abstract][Full Text] [Related]
13. A review of the utility of tacrolimus in the management of adults with autoimmune hepatitis.
Hanouneh M; Ritchie MM; Ascha M; Ascha MS; Chedid A; Sanguankeo A; Zein NN; Hanouneh IA
Scand J Gastroenterol; 2019 Jan; 54(1):76-80. PubMed ID: 30650311
[TBL] [Abstract][Full Text] [Related]
14. Increased numbers of CD5+CD19+CD1dhighIL-10+ Bregs, CD4+Foxp3+ Tregs, CD4+CXCR5+Foxp3+ follicular regulatory T (TFR) cells in CHB or CHC patients.
Wang L; Qiu J; Yu L; Hu X; Zhao P; Jiang Y
J Transl Med; 2014 Sep; 12():251. PubMed ID: 25199644
[TBL] [Abstract][Full Text] [Related]
15. The proportion of regulatory T cells in peripheral blood of patients with autoimmune hepatitis: A systematic review and meta-analysis.
Huang Z; Nie S; Wang H; Yan W; Tian D; Liu M
Int Immunopharmacol; 2023 Sep; 122():110576. PubMed ID: 37390643
[TBL] [Abstract][Full Text] [Related]
16. A multifaceted imbalance of T cells with regulatory function characterizes type 1 autoimmune hepatitis.
Ferri S; Longhi MS; De Molo C; Lalanne C; Muratori P; Granito A; Hussain MJ; Ma Y; Lenzi M; Mieli-Vergani G; Bianchi FB; Vergani D; Muratori L
Hepatology; 2010 Sep; 52(3):999-1007. PubMed ID: 20683931
[TBL] [Abstract][Full Text] [Related]
17. Aetiopathogenesis of autoimmune hepatitis.
Vergani D; Mieli-Vergani G
World J Gastroenterol; 2008 Jun; 14(21):3306-12. PubMed ID: 18528928
[TBL] [Abstract][Full Text] [Related]
18. The Imbalance between Foxp3
Liang M; Liwen Z; Yun Z; Yanbo D; Jianping C
J Immunol Res; 2018; 2018():3753081. PubMed ID: 30050955
[TBL] [Abstract][Full Text] [Related]
19. 'De novo' and 'recurrent' autoimmune hepatitis after liver transplantation: A comprehensive review.
Kerkar N; Yanni G
J Autoimmun; 2016 Jan; 66():17-24. PubMed ID: 26377632
[TBL] [Abstract][Full Text] [Related]
20. Sirolimus vs mycophenolate moftile in Tacrolimus based therapy following induction with Antithymocyte globulin promotes regulatory T cell expansion and inhibits RORγt and T-bet expression in kidney transplantation.
Jamali S; Sarafnejad A; Ahmadpoor P; Nafar M; Karimi M; Eteghadi A; Yekaninejad MS; Amirzargar AA
Hum Immunol; 2019 Sep; 80(9):739-747. PubMed ID: 30597187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
